Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001010208 | SCV001170367 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-05-17 | criteria provided, single submitter | clinical testing | The c.1185_1186delAC pathogenic mutation, located in coding exon 4 of the MSH6 gene, results from a deletion of two nucleotides at nucleotide positions 1185 to 1186, causing a translational frameshift with a predicted alternate stop codon (p.Y397Cfs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Mendelics | RCV002249630 | SCV002517640 | pathogenic | Endometrial carcinoma | 2022-05-04 | criteria provided, single submitter | clinical testing |